Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Direct Rapid Antibiotic Susceptibility Testing (dRAST) on Treatment for Bacteremia in Patients With Hematologic Diseases: Randomized Controlled Trial

NCT03611257 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03611257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Direct Rapid Antibiotic Susceptibility Testing (dRAST) on Treatment for Bacteremia in Patients With Hematologic Diseases: Randomized Controlled Trial
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2018
Completion date
October 10, 2019
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia sepsis, hematologic diseases